Keeping Track: First RMAT Approval On The Horizon; Big Weeks For Merck, Lilly And Celgene

 
• By Michael Cipriano, Brenda Sandburg, Bridget Silverman, and Jessica Merrill
  
Keeping Track Feature image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet